| 1050 |
50 mg |
Cerebrosides |
| Galactosylceramide, ceramide beta-D-galactoside |
| 1066 |
10 mg |
Cerebrosides; Kerasin (top spot) |
| Galactosylceramide with mostly non-hydroxy fatty acid side chain |
| 1138 |
10 mg |
Cerebrosides; Phrenosin, (bottom spot) |
| Galactosylceramide with mostly 2-hydroxy fatty acid side chains |
| 1305 |
10 mg |
Psychosine, (free amine form) |
| lyso-Cerebroside; 1-beta-D-galactosylsphingosine |
| 1325 |
10 mg |
N-Acetyl-psychosine |
| C2-Cerebroside |
| 1334 |
10 mg |
N-Octanoyl-beta-D-galactosylceramide |
| N-C8:0-Galactosylceramide |
| 1335 |
5 mg |
N-Pentadecanoyl-psychosine |
| N-C15:0-Cerebroside |
| 1621 |
100 µg |
N-Hexanoyl-NBD-galactosylceramide |
| N-C6:0-NBD-beta-D-galactosylsphingosine; N-C6:0-NBD-cerebroside; N-C6:0-NBD-galactosylceramide, fluorescent |
| 1633 |
100 µg |
N-Dodecanoyl-NBD-galactosylceramide |
| N-C12:0-NBD-beta-D-Galactosylsphingosine; N-C12:0-NBD-Cerebrosidee |
| 1633-001 |
1 mg |
N-Dodecanoyl-NBD-galactosylceramide |
| N-C12:0-NBD-beta-D-Galactosylsphingosine; N-C12:0-NBD-Cerebrosidee |
| 1914 |
5 mg |
N-Octadecanoyl-D35-psychosine, perdeuterated |
| Cerebrosides with C18-D35 fatty acid side chain |
| 1937 |
10 mg |
N-Dodecanoyl-beta-D-galactosylceramide |
| N-C12:0-Galactosylceramide; N-Dodecanoyl-beta-D-galactosylsphingosine |
| 1937-50 |
50 mg |
N-Dodecanoyl-beta-D-galactosylceramide |
| N-C12:0-Galactosylceramide; N-Dodecanoyl-beta-D-galactosylsphingosine |
| 2054 |
500 µg |
N-omega-CD3-Octadecanoyl disialoganglioside GD3 |
| N-CD3-Stearoyl GD3 |
| 2203 |
5 mg |
N-Hexanoyl-biotin-galactosylceramide |
| N-C6:0-Biotin-beta-D-galactosylsphingosine; N-C6:0-Biotin-cerebroside |
info@technochemical.com